Akèy › Kansè pwostat › Virginia
Etid klinik pou Kansè pwostat nan Virginia
54 etid pou Kansè pwostat ap chèche patisipan nan sit nan Virginia.
Vil nan Virginia
Tèks ofisyèl etid la (Anglè)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Virginia Cancer Specialists, Fairfax
Ap rekriteFaz 1/2
Laj 12 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT04585750Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- Hematology Oncology Associates of Fredericksburg Inc, Fredericksburg
- VCU Massey Cancer Center at Stony Point, Richmond
- VCU Massey Comprehensive Cancer Center, Richmond
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Oct 2, 2026 · NCT06931340Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Chesapeake Regional Medical Center, Chesapeake
- Augusta Health Center for Cancer and Blood Disorders, Fishersville
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- ak 7 plis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 40 a 75 · Tout sèks · Mizajou Oct 2, 2026 · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- Bon Secours Saint Francis Medical Center, Midlothian
- Bon Secours Richmond Community Hospital, Richmond
- ak 4 plis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 2, 2026 · NCT06632977Autonomic and Renal Contributions to Hypertension With ADT
- Virginia Commonwealth University, Richmond
Ap rekriteFaz 4Volontè an sante akeyi
Laj 40 ak plis · Gason · Mizajou Sep 30, 2026 · NCT07848828Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
- Hampton University Proton Therapy Institute, Hampton
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 29, 2026 · NCT01492972Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
- Virginia Urology Center, Richmond
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 28, 2026 · NCT06496256Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Virginia Clinical Research, Norfolk
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Sep 25, 2026 · NCT06800313A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
- University of Virginia Health System ( Site 0054), Charlottesville
- Inova Schar Cancer Institute ( Site 0017), Fairfax
- Virginia Cancer Specialists (VCS) ( Site 8004), Fairfax
- ak 2 plis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT06136650This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Blue Ridge Cancer Care, Blacksburg
- University of Virginia Comprehensive Cancer Center, Charlottesville
- University of Virginia, Charlottesville
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 24, 2026 · NCT07028853Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- Virginia Cancer Specialists, Fairfax
- Onco Hemato Asso of SW Virginia, Roanoke
Ap rekriteFaz 2/3
Laj 18 a 100 · Gason · Mizajou Sep 22, 2026 · NCT06780670A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Virginia Cancer Center, Charlottesville
- Virginia Cancer Specialists PC, Leesburg
- Bon Secours Cancer Institute at Saint Francis, Midlothian
- ak 1 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 22, 2026 · NCT07213674A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
- Research Site, Norfolk
- Research Site, Roanoke
- Research Site, Virginia Beach
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 18, 2026 · NCT06952803A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
- Blue Ridge Cancer Care ( Site 0024), Roanoke
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 17, 2026 · NCT06925737Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer
- Virginia Oncology Associates - Hampton, Norfolk
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 15, 2026 · NCT07493512Sacral Neuromodulation for Male Overactive Bladder (MOAB)
- Potomac Urology, Woodbridge
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Sep 14, 2026 · NCT06511141Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- Augusta Health Center for Cancer and Blood Disorders, Fishersville
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- VCU Massey Cancer Center at Hanover Medical Park, Mechanicsville
- ak 5 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05946213Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
- Investigational Site number: 404, Fairfax
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Sep 10, 2026 · NCT05997615A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
- NEXT Oncology, Fairfax
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06440005A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer
- University of Virginia Cancer Center, Charlottesville
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Sep 3, 2026 · NCT07005154Prostate Active Surveillance Study
- Eastern Virginia Medical School, Norfolk
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Gason · Mizajou Sep 2, 2026 · NCT00756665The Vanguard Study: Testing a New Way to Screen for Cancer
- Sentara Martha Jefferson Hospital, Charlottesville
- Inova Schar Cancer Institute, Fairfax
- Inova Fair Oaks Hospital, Fairfax
- ak 5 plis
Ap rekriteVolontè an sante akeyi
Laj 45 a 75 · Tout sèks · Mizajou Sep 2, 2026 · NCT06995898Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Virginia Cancer Specialists, Fairfax
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 24, 2026 · NCT07745361Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
- Virginia Cancer Specialists PC, Fairfax
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Aug 21, 2026 · NCT04221542A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
- NEXT Oncology - Virginia, Fairfax
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Aug 20, 2026 · NCT06785636Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- University of Virginia Cancer Center, Charlottesville
- VCU Massey Comprehensive Cancer Center, Richmond
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Aug 19, 2026 · NCT04423211Water Vapor Ablation for Prostate Cancer: Long-Term Registry
- Urology of Virginia, Virginia Beach
Ap rekriteEtid obsèvasyon
Tout laj · Gason · Mizajou Aug 18, 2026 · NCT07455058A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- University of Virginia Comprehensive Cancer Center, Charlottesville
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Aug 17, 2026 · NCT06842498FOG-001 in Locally Advanced or Metastatic Solid Tumors
- University of Virginia, Charlottesville
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 17, 2026 · NCT05919264PSMA PET Combined With MRI for the Detection of PCa
- Urology of Virginia, Virginia Beach
Ap rekriteFaz 3Volontè an sante akeyi
Laj 18 ak plis · Gason · Mizajou Jul 23, 2026 · NCT07052214Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
- University of Virginia Cancer Center, Charlottesville
- Bon Secours Memorial Regional Medical Center, Mechanicsville
- Bon Secours Saint Francis Medical Center, Midlothian
- ak 3 plis
Ap rekriteFaz 3
Laj 18 ak plis · Gason · Mizajou Jul 14, 2026 · NCT06592924Study of ORIC-944 in Patients With Metastatic Prostate Cancer
- Virginia Oncology Associates, Fairfax
- Virginia Cancer Specialists, Norfolk
Ap rekriteFaz 1
Laj 18 ak plis · Gason · Mizajou Jul 9, 2026 · NCT05413421Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- Inova Schar Cancer Institute, Fairfax
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Jun 17, 2026 · NCT00969111HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
- University of Virginia, Charlottesville
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Jun 12, 2026 · NCT07441889A Feasibility Study of Biometric Measurements Via Wearable Smart Watch Technology for Evaluation of Vasomotor Symptoms in Patients Treated With Androgen Deprivation Therapy for Prostate Cancer (Prostate 007)
- University of Virginia Health System, Charlottesville
Ap rekrite
Laj 18 ak plis · Gason · Mizajou Jun 9, 2026 · NCT07535541A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of INV-9956 in Adult Patients With Advanced Metastatic Castration Resistant Prostate Cancer
- NEXT Oncology, Fairfax
Ap rekriteFaz 1/2
Laj 18 ak plis · Gason · Mizajou Jun 4, 2026 · NCT06609005Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Onco Hemato Asso of SW Virginia, Roanoke
Ap rekriteFaz 4
Laj 18 a 100 · Gason · Mizajou Jun 4, 2026 · NCT05803941TERPS Trial for de Novo Oligometastic Prostate Cancer
- Bon Secours Cancer Institute at St. Francis, Midlothian
Ap rekriteFaz 2
Laj 18 ak plis · Gason · Mizajou Jun 3, 2026 · NCT05223803International Registry for Men With Advanced Prostate Cancer (IRONMAN)
- University of Virginia, Charlottesville
Ap rekriteEtid obsèvasyon
Laj 21 ak plis · Gason · Mizajou May 22, 2026 · NCT03151629Remotely Monitored Exercise Interventions in Patients With mCSPC Undergoing ADT (Prostate 006)
- University of Virginia, Charlottesville
Ap rekrite
Laj 18 ak plis · Gason · Mizajou May 4, 2026 · NCT06429813Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.